Pfizer's antiviral Covid pill is here — and it might help end the pandemic. Here's howCNBC • 12/22/21
FDA authorizes Pfizer's Covid treatment pill, the first oral antiviral drug cleared during the pandemicCNBC • 12/22/21
The FDA just authorized the first pill to treat COVID-19, replenishing the tool kit of treatments against OmicronBusiness Insider • 12/22/21
Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral TreatmentBusiness Wire • 12/22/21
FDA To Possibly Authorize Pfizer, Merck COVID-19 Antiviral Pills This Week: BloombergBenzinga • 12/22/21
Pfizer to Provide the United Kingdom an Additional 2.5 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19Business Wire • 12/22/21
Five-Year Follow-Up Data Show Pfizer's Tafamidis Cuts Risk of Mortality by 41% In Cardiomyopathy PatientsBenzinga • 12/21/21
Stock Market Today: Stock Futures Rise After Omicron-Led Sell-Off; Nike and Micron Soar On Strong Earnings; Pfizer and GSK Make FDA Breakthrough With HIV DrugStockmarketcom • 12/21/21
Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative OptionBenzinga • 12/21/21
Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba® (isavuconazole) in ChinaGlobeNewsWire • 12/21/21
Pfizer's VYNDAQEL®/VYNDAMAX® Reduced the Risk of All-Cause Mortality by 41% Among Patients with Transthyretin Amyloid Cardiomyopathy, Five-Year Follow-Up Data DemonstrateBusiness Wire • 12/20/21
